Viewing StudyNCT00117429



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00117429
Status: COMPLETED
Last Update Posted: 2010-02-15
First Post: 2005-06-30

Brief Title: Study of the HIV gp120NefTatAS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy HAART
Sponsor: Marcus Altfeld MD PhD
Organization: Marcus Altfeld MD PhD

Organization Data

Organization: Marcus Altfeld MD PhD
Class: INDIV
Study ID: PARC001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Marcus Altfeld MD PhD
Lead Sponsor Class: INDIV
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Marcus Altfeld
Old Organization: Massachusetts General Hosptial

Collaborators

Name Class
GlaxoSmithKline INDUSTRY